ARCHIVES

Cuts Claimed to Displace “Millions” of Patients Yet None Seem to Complain. Why Not?

This article is from The Cancer Letter archive.

Vol. 39 No. 17 | April 25, 2013

Download PDF Visit The Full Archive

Related Articles

Research Training – On The Road Back, With Trainee Stipends, Payback Feature

June 14, 1974

Study: Angiopoietin-2 Levels May Predict Lenvatinib Response

October 31, 2014

Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.

November 9, 2001

NCI Payline For Fiscal 1986 To Be 160 or 165

October 11, 1985

Iniparib Plus Chemo Shows Benefit In Phase II Study

January 28, 2011

Burzynski, Monaco Clashed In Court

June 5, 1992